Kalderos Wants to Give Drug Manufacturers a Way to Pay 340B Rebates in Lieu of Discounts
Prescription drug information technology company Kalderos announced today it is launching a platform called 340B Pay on Sept. 8 “to facilitate 340B discounts via a rebate.” Several drug manufacturers are adopting the platform, Kalderos told 340B Report, including “some emerging manufacturers that will leverage our innovative platform from launch.”
Kalderos Founder and CEO Jeremy Docken and prescription drug economics and drug supply chain blogger Adam Fein are co-hosting a webinar on 340B Pay on Sept. 11 beginning at noon Eastern, in part to explain “how covered entities, manufacturers, state Medicaid programs, and other stakeholders will benefit from 340B rebates.”
×